FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
Articles

How AI and Digital Innovation Are Transforming the Future of the FinTech Industry

Admin Aug 11, 2026 0
Whitepaper

The Power of Ecosystems for Banking

Articles

The Rise of Fintech: Transforming the Financial Landscape

Articles

Why Financial Services and Banks Need an Operational Data Layer

Articles

FinTech Futures: How Media, Advertising & Marketing Are Shaping…

Articles

If little is done to stop capitalism from doing harm, its claim to be a positive…

Admin Jun 10, 2026
Capitalism has long been celebrated as one of the most powerful economic systems ever created. It has driven…
Whitepaper

The Fundamentals of a Personalized Digital Banking Experience

Admin Jun 9, 2026
The expectations today's customers have towards personalized digital banking are directly impacted by their…
Infographics

What is an Unsecured Loan? A Complete Guide for Borrowers

Admin Jun 8, 2026
In today's fast-paced world, financial needs can arise unexpectedly. Whether it's for medical emergencies,…
Articles

The Future of Payments: Fintech Innovation and NetSuite Integration

Admin Jun 5, 2026
The world of finance is undergoing a rapid transformation, driven by the rise of fintech. One of the most…
Articles

Finance: The Evolution of Financial Services

Admin Jun 4, 2026
The financial sector is embracing rapid technological advancements that are reshaping the way businesses and…
Articles

The Role of Big Data in FinTech: Driving Better Financial Decisions

Admin Jun 3, 2026
The intersection of Big Data and FinTech has created a dynamic new era for financial services. As financial…
Whitepaper

Finance Automation: Thriving in the Age of Change

Admin Jun 2, 2026
While most accounting teams have replaced their manual accounting practices with an updated, digital version, many…
Articles

Open Banking and Trust, a key issue

Admin Jun 1, 2026
Open Banking is all about the customer being in control of their data and funds. It gives them the freedom…
Whitepaper

Cards and Payments: Delivering the Digital Opportunity

Admin May 29, 2026
New technology has always presented card issuers, whether they are banks or retailers, with challenges and…
Whitepaper

Banking, Finance & Investment

Admin May 28, 2026
Banks and financial institutions take legal support from lawyers for security documentation, for example,…
Whitepaper

“Generative AI Trends Among U.S. Financial Advisors and Consumers”

Admin May 26, 2026
Discover the latest insights on how financial advisors and their clients embrace generative AI. This report dives…
Whitepaper

Financial Services for Agriculture

Admin May 25, 2026
“RBC understood our business and provided us with the financial tools we needed to continue to expand and at the…
Banking

Embedded Finance and Open Banking Redefine Financial Services

Admin May 20, 2026
The fintech sector is experiencing a new wave of innovation with the rapid adoption of embedded finance and open…
Articles

Life After QuickBooks: Why It’s Time to Step Up to Sage Intacct for Business-Class…

Admin May 18, 2026
For many small and midsized businesses, Intuit QuickBooks is the preferred choice for financial software in the…
Whitepaper

How Your Personality Is Impacting Your Finances

Admin May 15, 2026
Your personality impacts how you make decisions in almost every area of your life. Your career, relationships,…
Articles

Understanding Credit Card Losses: Causes, Prevention, and Recovery

Admin May 14, 2026
Credit cards are a convenient financial tool used by millions of people worldwide for everyday purchases,…
Whitepaper

Everything You Should Know About Contactless Payments

Admin May 13, 2026
For years, shoppers in Europe and Asia have been paying with contactless methods such as mobile wallets and…
Whitepaper

Embedded banking but not as you know it

Admin May 12, 2026
Every now and then the fintech sector finds itself impacted by a wave of technological innovation, which marks the…
Articles

How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026

Admin May 11, 2026
In today’s fast-moving world, finance is no longer just about saving money in a bank account or investing in…
Whitepaper

INVESTMENT GUIDE Investing for your future

Admin May 8, 2026
Everything we do at Australian Super is designed to help everyday Australians achieve their best retirement. As…
Whitepaper

5 Approaches to Scaling Finance Accuracy with AI

Admin May 6, 2026
Finance teams often waste hours reconciling spreadsheets, documenting controls, and applying business logic…
Whitepaper

Understanding the Financial Interest Clause

Admin May 5, 2026
A Financial Interest Clause (FIC) is one of many options available to companies with multinational exposures. Like…
Banking

How the Fintech Industry is Redefining the Future of Financial Services

Admin May 4, 2026
The banking profession has undergone a remarkable transformation over the past few decades, shifting from…
Featured News

Global Financial Markets Navigate Volatility Amid Rate Uncertainty and Digital…

Admin Apr 30, 2026
Global financial markets today are witnessing a cautious yet dynamic phase as investors, policymakers, and…
Featured News

Fintech Disruption Meets Taxation Reform: Digital Finance Reshapes Global…

Admin Apr 29, 2026
The convergence of fintech innovation and evolving taxation frameworks is emerging as one of the most…
Whitepaper

Climate-Related Financial Risk

Admin Apr 28, 2026
Climate-related financial risk has become a prominent theme that is high on the agenda of U.S. and European…
Infographics

10 Ways AI Chatbots Can Transform the Banking Industry

Admin Apr 27, 2026
A chatbot is a piece of software that can share information and answer questions in a conversational style.…
Featured News

AI-Powered Fintech Revolution Reshapes Global Banking and Payments in 2026

Admin Apr 24, 2026
The global fintech industry in 2026 is undergoing a rapid transformation driven by artificial intelligence,…
Articles

AI in Banking: A Review of the Top 7 Banks in America

Admin Apr 23, 2026
Even the established banks are beginning to show interest in and implement artificial intelligence (AI), despite…
Featured News

Volatility Surges as Global Events Reshape Currency Markets

Admin Apr 22, 2026
The global forex trading landscape in 2026 is witnessing heightened volatility as geopolitical tensions, central…
Articles

Cylinder Crisis in India: Rising LPG Costs Push Households Toward Financial Strain

Admin Apr 21, 2026
India is currently witnessing a growing concern over the rising cost and accessibility of domestic LPG cylinders,…
Articles

The Best Advanced Payment Options You Should Be Aware Of

Admin Apr 16, 2026
Essential Payment Solutions for Your Business Running a business involves many considerations, with payment…
Previous 1 2 3 4 … 14 Next

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • How AI and Digital Innovation Are Transforming the Future of the FinTech Industry
    • The Power of Ecosystems for Banking
    • The Rise of Fintech: Transforming the Financial Landscape
    • Why Financial Services and Banks Need an Operational Data Layer
    • FinTech Futures: How Media, Advertising & Marketing Are Shaping the Next Generation of Financial Services

    ARTICLE

    Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
    2026-08-12T11:30:00Z
    Received FDA clearance of IND application for XTX501, a potential best-in-class bispecific PD-1 / masked IL-2


    BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights
    2026-08-12T11:30:00Z
    Record second quarter 2026 revenue increased 35% to $17.1 million, compared with Q2 2025


    PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results
    2026-08-12T11:30:00Z
    FDA Accepted D-PLEX₁₀₀ NDA with Priority Review; PDUFA Goal Date of November 28, 2026, Approximately One Quarter Ahead of Previously Communicated Guidance


    Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
    2026-08-12T11:30:00Z
    Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been...


    Altimmune Announces Second Quarter 2026 Financial Results and Business Update
    2026-08-12T11:30:00Z
    Initiated global PERFORMA Phase 3 trial in MASH


    Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-12T11:30:00Z
    Maintained strong financial position with cash, cash equivalents and marketable securities of $92.6M as of June 30, 2026


    Novonesis launches Optiva® Triticum to help pasta manufacturers navigate wheat volatility without compromising quality
    2026-08-12T11:12:02Z
    COPENHAGEN, Denmark, August 12, 2026 – Novonesis today announced the launch of Optiva® Triticum, a new biosolution that helps pasta manufacturers increase flexibility in wheat sourcing while maintaining the texture, firmness...


    Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-12T11:08:47Z
    Over 50% of commercially insured lives in the U.S., representing a recent and significant increase, now have coverage for CARDAMYST® (etripamil) nasal spray


    Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
    2026-08-12T11:05:00Z
    – Newly granted patent extends protection for ATH434 to at least 2045, significantly enhancing its strategic value and long-term commercial potential –


    Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance
    2026-08-12T11:05:00Z
    REHOVOT, Israel and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare...


    TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-12T11:00:00Z
    First patient dosed in Phase 3 ALLOHA-2™ study; topline readout expected mid-2028


    Kamada Announces Planned Transition of Chief Financial Officer
    2026-08-12T11:00:00Z
    REHOVOT, Israel, and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare...


    Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
    2026-08-12T11:00:00Z
    NEWTON, Mass., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta...


    Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
    2026-08-12T11:00:00Z
    Finalized SUNRISE-FA 2 open-label, pivotal trial protocol and SAP for LX2006 in support of accelerated approval pathway; topline data expected in second half of 2027


    Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
    2026-08-12T11:00:00Z
    – Breakthrough results from V012 dialysis access Phase 3 study, where ATEV was observed to outperform AV fistula; supplemental Biologic License Application (sBLA) for dialysis access to be filed with...


    Attralus Has Been Granted U.S. FDA Fast Track Designation for Zamubafusp Alfa (AT-02) for the Treatment of AL Amyloidosis
    2026-08-12T11:00:00Z
    NAPLES, Fla., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today announced that...


    Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
    2026-08-12T11:00:00Z
    BROOMFIELD, Colo., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms...


    Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates
    2026-08-12T11:00:00Z
    Namodenoson Holds FDA Fast Track and U.S. and European Orphan Drug Designations; Piclidenoson and Namodenoson Are Advancing in Phase III Programs


    Persephone Biosciences Publishes Largest U.S. Clinical Study of an Infant Synbiotic in Pediatric Research, Expanding Clinical Evidence for Its Infant Synbiotics
    2026-08-12T11:00:00Z
    Publication reports results from the largest U.S. randomized trial evaluating a synergistic Bifidobacterium-HMO synbiotic in infants and toddlers, demonstrating safety, successful gut colonization and biologically meaningful microbiome changes.


    LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer
    2026-08-12T11:00:00Z
    On Track to Complete Enrollment of the Phase 3 ELAINE-3 clinical trial in 4Q 2026 with Topline Data Expected in 2H 2027


    Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study
    2026-08-12T11:00:00Z
    – Encouraging early clinical activity including confirmed and ongoing unconfirmed partial responses with favorable tolerability, and pharmacokinetics (PK) observed in ongoing STRO-004 Phase 1 study –


    Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update
    2026-08-12T10:50:00Z
    ZUG, Switzerland, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living...


    Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones
    2026-08-12T10:05:00Z
    Rapid, Positive Clinical Outcomes in GBS FORWARD Study Reinforce Consistency and Reproducibility of Tanruprubart Treatment Effect Demonstrated in Phase 3 and Real-World Evidence Studies; BLA Submission Expected in Q4 2026


    Annexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension Study
    2026-08-12T10:00:00Z
    BRISBANE, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory diseases that impact nearly...


    Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases
    2026-08-12T09:00:00Z
    COPENHAGEN, Denmark, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SNIPR today announced the publication of a peer-reviewed expanded access case report in Clinical Infectious Diseases https://doi.org/10.1093/cid/ciag446 describing the use of SNIPR001 in...


    Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement
    2026-08-12T08:00:00Z
    Expanded financing broadens Rakovina’s strategic investor base and reinforces confidence in its AI-powered oncology platform


    BioPorto A/S to host an investor webcast on the results for the first half of 2026 
    2026-08-12T07:29:49Z


    FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
    2026-08-12T01:10:17Z
    FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares


    Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering
    2026-08-12T00:01:00Z
    GRAND CAYMAN, Cayman Islands, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for...


    Anteris Technologies Announces Results for the Second Quarter of 2026
    2026-08-11T23:00:00Z
    MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing,...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.